Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Seley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Tezacitabine Hoechst Marion RousselK L Seley
Idrugs : the Investigational Drugs Journal|July 22, 2005
CoFactor (Biokeys Pharmaceuticals)K L Seley
Organic Letters|September 28, 2001
"Fleximers". Design and synthesis of two novel split nucleosidesK L Seley, L Zhang, A Hagos
Journal of Medicinal Chemistry|June 17, 1998
Does the anti-hepatitis B virus activity of (+)-5'-noraristeromycin exist in its 4'-epimer and 4'-deoxygenated derivatives?K L Seley, S W Schneller, B Korba
Journal of Medicinal Chemistry|April 25, 1997
Carbocyclic oxetanocins lacking the C-3' methyleneJ Wu, S W Schneller, K L Seley
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
Carbocyclic 5'-noruridineV R Hegde, K L Seley, S W Schneller
Current Medicinal Chemistry|August 19, 2015
Flexibility as a Strategy in Nucleoside Antiviral Drug DesignH L Peters, T C Ku, K L Seley-Radtke
Journal of Medicinal Chemistry|February 14, 1997
(+)-7-Deaza-5'-noraristeromycin as an anti-trypanosomal agentK L Seley, S W Schneller, D Rattendi, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis and antitumor activity of thieno-separated tricyclic purinesK L Seley, P Januszczyk, A Hagos, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Synthesis and antitrypanosomal activities of a series of 7-deaza-5'-noraristeromycin derivatives with variations in the cyclopentyl ring substituentsK L Seley, S W Schneller, D Rattendi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Tezacitabine Hoechst Marion RousselK L Seley
Idrugs : the Investigational Drugs Journal|July 22, 2005
CoFactor (Biokeys Pharmaceuticals)K L Seley
Organic Letters|September 28, 2001
"Fleximers". Design and synthesis of two novel split nucleosidesK L Seley, L Zhang, A Hagos
Journal of Medicinal Chemistry|June 17, 1998
Does the anti-hepatitis B virus activity of (+)-5'-noraristeromycin exist in its 4'-epimer and 4'-deoxygenated derivatives?K L Seley, S W Schneller, B Korba
Journal of Medicinal Chemistry|April 25, 1997
Carbocyclic oxetanocins lacking the C-3' methyleneJ Wu, S W Schneller, K L Seley
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
Carbocyclic 5'-noruridineV R Hegde, K L Seley, S W Schneller
Current Medicinal Chemistry|August 19, 2015
Flexibility as a Strategy in Nucleoside Antiviral Drug DesignH L Peters, T C Ku, K L Seley-Radtke
Journal of Medicinal Chemistry|February 14, 1997
(+)-7-Deaza-5'-noraristeromycin as an anti-trypanosomal agentK L Seley, S W Schneller, D Rattendi, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis and antitumor activity of thieno-separated tricyclic purinesK L Seley, P Januszczyk, A Hagos, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Synthesis and antitrypanosomal activities of a series of 7-deaza-5'-noraristeromycin derivatives with variations in the cyclopentyl ring substituentsK L Seley, S W Schneller, D Rattendi, et al.
Pageof 2